| Product NDC: | 67919-020 |
| Proprietary Name: | Entereg |
| Non Proprietary Name: | alvimopan |
| Active Ingredient(s): | 12 mg/1 & nbsp; alvimopan |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67919-020 |
| Labeler Name: | Cubist Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021775 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120416 |
| Package NDC: | 67919-020-10 |
| Package Description: | 6 BLISTER PACK in 1 CARTON (67919-020-10) > 5 CAPSULE in 1 BLISTER PACK |
| NDC Code | 67919-020-10 |
| Proprietary Name | Entereg |
| Package Description | 6 BLISTER PACK in 1 CARTON (67919-020-10) > 5 CAPSULE in 1 BLISTER PACK |
| Product NDC | 67919-020 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alvimopan |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120416 |
| Marketing Category Name | NDA |
| Labeler Name | Cubist Pharmaceuticals, Inc. |
| Substance Name | ALVIMOPAN |
| Strength Number | 12 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |